Swartz Holly A, Cyranowski Jill M, Cheng Yu, Zuckoff Allan, Brent David A, Markowitz John C, Martin Stacy, Amole Marlissa C, Ritchey Fiona, Frank Ellen
University of Pittsburgh School of Medicine, Pittsburgh.
Chatham University, Pittsburgh.
J Am Acad Child Adolesc Psychiatry. 2016 Jun;55(6):495-503.e2. doi: 10.1016/j.jaac.2016.04.003. Epub 2016 Apr 7.
Two-generation studies demonstrate that treating maternal depression benefits school-age children. Although mothers prefer psychotherapy to medication, little is known about how psychotherapy for maternal depression affects offspring, especially in very high-risk families in which both mothers and children concurrently meet syndromal criteria for psychiatric disorders. This trial evaluated the effects of 2 brief psychotherapies for maternal depression on very high-risk families.
Mothers with major depressive disorder were randomly assigned to 9 sessions of either brief interpersonal psychotherapy for mothers (IPT-MOMS; n = 85) or brief supportive psychotherapy (BSP; n = 83). Independent assessors evaluated mothers and their children, ages 7 to 18 years, diagnosed with at least 1 internalizing disorder, every 3 months over the course of 1 year.
Symptoms and functioning of mothers and children improved significantly over time, with no between-group differences. However, children of mothers assigned to BSP had more outpatient mental health visits and were more likely to receive antidepressant medication. Mothers reported greater satisfaction with IPT-MOMS than BSP. Improvement in mothers' depressive symptoms was associated with improvement in child functioning in time-lagged fashion, with children improving 3 to 6 months after mothers improved. Antidepressant medication use and number of mental health visits received by children did not affect outcomes.
IPT-MOMS and BSP demonstrated comparable beneficial effects on maternal depression. Children's functioning improved following maternal improvement, independent of youths' treatment. Children of mothers randomized to IPT-MOMS, compared with BSP, achieved comparable outcomes despite less follow-up treatment. Observation of lagged association between maternal improvement and change in child functioning should influence treatment planning for families. Clinical trial registration information-Psychotherapy for Depressed Mothers of Psychiatrically Ill Children; http://clinicaltrials.gov/; NCT00919594.
两代人研究表明,治疗母亲的抑郁症对学龄儿童有益。尽管母亲们更倾向于心理治疗而非药物治疗,但对于母亲抑郁症的心理治疗如何影响后代,尤其是在母亲和孩子同时符合精神疾病综合征标准的极高风险家庭中,人们了解甚少。本试验评估了两种针对母亲抑郁症的简短心理治疗对极高风险家庭的影响。
患有重度抑郁症的母亲被随机分配接受9次针对母亲的简短人际心理治疗(IPT - MOMS;n = 85)或简短支持性心理治疗(BSP;n = 83)。独立评估人员在1年的时间里,每3个月对母亲及其7至18岁、被诊断患有至少一种内化性障碍的孩子进行评估。
随着时间推移,母亲和孩子的症状及功能显著改善,组间无差异。然而,被分配到BSP的母亲的孩子有更多的门诊心理健康就诊次数,且更有可能接受抗抑郁药物治疗。母亲们对IPT - MOMS的满意度高于BSP。母亲抑郁症状的改善与孩子功能的改善呈时间滞后相关,孩子在母亲改善3至6个月后有所改善。孩子使用抗抑郁药物的情况和接受心理健康就诊的次数并未影响结果。
IPT - MOMS和BSP对母亲抑郁症显示出相当的有益效果。母亲病情改善后,孩子的功能得到改善,与青少年接受的治疗无关。与BSP相比,被随机分配到IPT - MOMS的母亲的孩子尽管接受的后续治疗较少,但仍取得了相当的结果。观察到母亲病情改善与孩子功能变化之间的滞后关联应会影响家庭的治疗计划。临床试验注册信息——精神病患儿抑郁母亲的心理治疗;http://clinicaltrials.gov/;NCT00919594。